千红制药（002550）8月14日主力资金净流出2961.81万元

Core Points - The stock price of Qianhong Biopharma (002550) closed at 10.05 yuan on August 14, 2025, down by 0.69% with a turnover rate of 5.15% and a trading volume of 493,200 hands, amounting to 497 million yuan in transaction value [1] - The latest financial report for Qianhong Biopharma shows total operating revenue of 451 million yuan for Q1 2025, a year-on-year decrease of 2.22%, while net profit attributable to shareholders reached 161 million yuan, a year-on-year increase of 54.62% [1] - The company has a current ratio of 10.220, a quick ratio of 8.201, and a debt-to-asset ratio of 9.29% [1] Financial Performance - Qianhong Biopharma's Q1 2025 operating revenue was 451 million yuan, down 2.22% year-on-year [1] - The net profit attributable to shareholders was 161 million yuan, up 54.62% year-on-year [1] - The company's non-recurring net profit was 107 million yuan, reflecting a year-on-year increase of 4.84% [1] Capital Flow - On the trading day, the net outflow of main funds was 29.618 million yuan, accounting for 5.96% of the transaction value [1] - Large orders saw a net outflow of 22.4834 million yuan, representing 4.53% of the transaction value [1] - Small orders experienced a net inflow of 53.6904 million yuan, which is 10.81% of the transaction value [1] Company Background - Qianhong Biopharma, established in 2003 and located in Changzhou, primarily engages in the pharmaceutical manufacturing industry [2] - The company has a registered capital of 1.2798 billion yuan and a paid-in capital of 601.725 million yuan [1][2] - The legal representative of the company is Wang Ke [1]